Upload
stuart-knight
View
221
Download
1
Tags:
Embed Size (px)
Citation preview
20/03/200820/03/2008 Dept. of PharmaceuticsDept. of Pharmaceutics 11
Nanotechnology Based Drug DeliveryNanotechnology Based Drug Delivery
Dr. Basavaraj K. Nanjwade Dr. Basavaraj K. Nanjwade M.Pharm., Ph.DM.Pharm., Ph.D
Associate ProfessorAssociate ProfessorDepartment of PharmaceuticsDepartment of Pharmaceutics
JN Medical CollegeJN Medical CollegeKLE UniversityKLE University
Belgaum-590010Belgaum-590010
20/03/200820/03/2008 Dept. of PharmaceuticsDept. of Pharmaceutics 22
Applications of NanotechnologyApplications of Nanotechnology
20/03/200820/03/2008 Dept. of PharmaceuticsDept. of Pharmaceutics 33
Targeted Drug DeliveryTargeted Drug Delivery
20/03/200820/03/2008 Dept. of PharmaceuticsDept. of Pharmaceutics 44
Nanoparticles for Drug DeliveryNanoparticles for Drug Delivery
Metal-based nanoparticlesMetal-based nanoparticles
Lipid-based nanoparticlesLipid-based nanoparticles
Polymer-based nanoparticlesPolymer-based nanoparticles
Biological nanoparticlesBiological nanoparticles
20/03/200820/03/2008 Dept. of PharmaceuticsDept. of Pharmaceutics 55
NanobiopharmaceuticalsNanobiopharmaceuticalsIn biopharmaceuticals, in addition to the In biopharmaceuticals, in addition to the main technologies covered-liposomal, main technologies covered-liposomal, monoclonal antibody-based, and polymer-monoclonal antibody-based, and polymer-based technologies host of newer based technologies host of newer technologies such as nanoparticles technologies such as nanoparticles including various nanodimensional entities including various nanodimensional entities such as molecular imprinted polymers, such as molecular imprinted polymers, metallofullerenes, prodrug delivery, oral, metallofullerenes, prodrug delivery, oral, injectable and implantable, pulmonary, and injectable and implantable, pulmonary, and transdermal and transmucosal delivery transdermal and transmucosal delivery have come up. have come up.
20/03/200820/03/2008 Dept. of PharmaceuticsDept. of Pharmaceutics 66
Drug Delivery Technology Important to Drug Delivery Technology Important to Pharma IndustryPharma Industry
Drug delivery formulations involve low cost Drug delivery formulations involve low cost research compared that for discovery of research compared that for discovery of new molecule, new molecule,
Minimizing the drug use would significantly Minimizing the drug use would significantly reduce the effective cost of drug which reduce the effective cost of drug which would give financial relief to the patients, would give financial relief to the patients,
20/03/200820/03/2008 Dept. of PharmaceuticsDept. of Pharmaceutics 77
Delivery systems increase commercial Delivery systems increase commercial opportunity by distinguishing a drug from opportunity by distinguishing a drug from competitive threats posed by “me too” competitive threats posed by “me too” drugs and drugs and
Novel means of delivery particularly using Novel means of delivery particularly using nano-carriers, can allow branded drugs to nano-carriers, can allow branded drugs to be rescued from abyss of generic be rescued from abyss of generic competition (may be called “resurrection of competition (may be called “resurrection of drug”). drug”).
Drug Delivery Technology Important to Drug Delivery Technology Important to Pharma IndustryPharma Industry
20/03/200820/03/2008 Dept. of PharmaceuticsDept. of Pharmaceutics 88
SOME SIGNIFICANT ACHIEVEMENTS OF SOME SIGNIFICANT ACHIEVEMENTS OF NANODEVICES NANODEVICES
Development of one dose a day ciprofloxacin using Development of one dose a day ciprofloxacin using nanotechnologynanotechnology
Tumor targeted taxol delivery using nanoparticles in Tumor targeted taxol delivery using nanoparticles in Phase 2 clinical trial stagePhase 2 clinical trial stage
Improved ophthalmic delivery formulation using Improved ophthalmic delivery formulation using smart hydrogel nanoparticlessmart hydrogel nanoparticles
Oral insulin formulation using nanoparticles carriers.Oral insulin formulation using nanoparticles carriers.
Liposomal based Amphotericin B formulationLiposomal based Amphotericin B formulation
20/03/200820/03/2008 Dept. of PharmaceuticsDept. of Pharmaceutics 99
CHALLENGESCHALLENGES
Prevention of drug from biological degradationPrevention of drug from biological degradation
Effective TargetingEffective Targeting
Patient CompliancePatient Compliance
Cost effectivenessCost effectiveness
Product life extensionProduct life extension
20/03/200820/03/2008 Dept. of PharmaceuticsDept. of Pharmaceutics 1010
PRIORITY AREASPRIORITY AREASCancer NanotechnologyCancer Nanotechnology
(i) (i) Diagnosis using Quantum Diagnosis using Quantum
DotsDots
(ii) Tumor Targeted Delivery(ii) Tumor Targeted Delivery
(iii) (iii) ImagingImaging
(iv) Cancer Gene Therapy(iv) Cancer Gene Therapy
20/03/200820/03/2008 Dept. of PharmaceuticsDept. of Pharmaceutics 1111
PRIORITY AREASPRIORITY AREAS
DNA Vaccines for parasitic, bacterial and DNA Vaccines for parasitic, bacterial and viral diseasesviral diseases
Oral and pulmonary routes for systemic Oral and pulmonary routes for systemic delivery of proteins and peptidesdelivery of proteins and peptides
Nanotechnology in Tissue EngineeringNanotechnology in Tissue Engineering
20/03/200820/03/2008 Dept. of PharmaceuticsDept. of Pharmaceutics 1212
Drug Delivery CarriersDrug Delivery Carriers
20/03/200820/03/2008 Dept. of PharmaceuticsDept. of Pharmaceutics 1313
Targeting LigandsTargeting Ligands
20/03/200820/03/2008 Dept. of PharmaceuticsDept. of Pharmaceutics 1414
Liposome's Liposome's
20/03/200820/03/2008 Dept. of PharmaceuticsDept. of Pharmaceutics 1515
Liposome'sLiposome's
Their exterior lipid bilayer is very chemically reactive, thereby providing a Their exterior lipid bilayer is very chemically reactive, thereby providing a means to conveniently couple “tags” on a covalent basis. means to conveniently couple “tags” on a covalent basis.
Such “tags” can be antibodies, antigens, cell receptors, nucleic acid Such “tags” can be antibodies, antigens, cell receptors, nucleic acid probes, etc. probes, etc.
This provides significant versatility in assay formats (i.e., immunoassay, This provides significant versatility in assay formats (i.e., immunoassay, receptor-based, nucleic acid probe, etc.) possible. receptor-based, nucleic acid probe, etc.) possible.
With diameters ranging in size from approximately 50 nm to 800 nm, their With diameters ranging in size from approximately 50 nm to 800 nm, their aqueous core encapsulates up to millions of molecules of signal generating aqueous core encapsulates up to millions of molecules of signal generating “markers” that can be detected in a variety of different way. “markers” that can be detected in a variety of different way.
A variety of different encapsulants are possible including visually A variety of different encapsulants are possible including visually detectable dyes (since the lipid bilayer is transparent), optically and detectable dyes (since the lipid bilayer is transparent), optically and fluorometrically detectable dyes, enzymes, and electroactive compounds. fluorometrically detectable dyes, enzymes, and electroactive compounds.
This provides significant versatility in the detection schemes possible.This provides significant versatility in the detection schemes possible.
20/03/200820/03/2008 Dept. of PharmaceuticsDept. of Pharmaceutics 1616
NiosomesNiosomes
20/03/200820/03/2008 Dept. of PharmaceuticsDept. of Pharmaceutics 1717
NiosomesNiosomesNiosomes, non-ionic surfactant vesicles, are widely studied as an Niosomes, non-ionic surfactant vesicles, are widely studied as an alternative to liposomesalternative to liposomes
These vesicles appear to be similar to liposomes in terms of their These vesicles appear to be similar to liposomes in terms of their physical propertiesphysical properties
They are also prepared in the same way and under a variety of They are also prepared in the same way and under a variety of conditions, from unilamellar or multilamellar structures.conditions, from unilamellar or multilamellar structures.
Niosomes alleviate the disadvantages associated with liposomes, Niosomes alleviate the disadvantages associated with liposomes, such as chemical instability, variable purity of phospholipids and such as chemical instability, variable purity of phospholipids and high cost.high cost.
They have the potential for controlled and targated drug deliveryThey have the potential for controlled and targated drug delivery
Niosomes enhanced the penetration of drugsNiosomes enhanced the penetration of drugs
20/03/200820/03/2008 Dept. of PharmaceuticsDept. of Pharmaceutics 1818
NanopowderNanopowder
20/03/200820/03/2008 Dept. of PharmaceuticsDept. of Pharmaceutics 1919
NanopowderNanopowderNanopowders are powders composed of Nanopowders are powders composed of nanoparticles, that is particles having an average nanoparticles, that is particles having an average diameter below 50 nanometers (nm). diameter below 50 nanometers (nm).
A jar of a true nanopowder when emptied from A jar of a true nanopowder when emptied from chest height to toward the floor will disperse into chest height to toward the floor will disperse into the air before reaching the floor. the air before reaching the floor.
Most manufacturers of “nanopowders” produce Most manufacturers of “nanopowders” produce micropowder assemblies of nanoparticles but the micropowder assemblies of nanoparticles but the powder itself is rarely a nanopowder. powder itself is rarely a nanopowder.
Such compounds have two or more different Such compounds have two or more different cations (positively charged elements) in their cations (positively charged elements) in their chemical formula. An example of a complex chemical formula. An example of a complex compound is calcium titanate (CaTiO3). compound is calcium titanate (CaTiO3).
20/03/200820/03/2008 Dept. of PharmaceuticsDept. of Pharmaceutics 2020
NanoclusterNanocluster
20/03/200820/03/2008 Dept. of PharmaceuticsDept. of Pharmaceutics 2121
NanoclusterNanoclusterOne of the central themes in nanoscience One of the central themes in nanoscience research is to synthesize high quality research is to synthesize high quality nanoparticles with precise control over nanoparticles with precise control over particle size, shape, structure, and particle size, shape, structure, and composition. composition.
For inorganic nanoparticles (e.g. metal and For inorganic nanoparticles (e.g. metal and semiconductor), two regimes are of semiconductor), two regimes are of particular interest, that is, nanoclusters in particular interest, that is, nanoclusters in a size range from subnanometer to ~2 nm a size range from subnanometer to ~2 nm and nanocrystals (typically 2-100 nm).and nanocrystals (typically 2-100 nm).
20/03/200820/03/2008 Dept. of PharmaceuticsDept. of Pharmaceutics 2222
NanocrystalsNanocrystals
20/03/200820/03/2008 Dept. of PharmaceuticsDept. of Pharmaceutics 2323
NanocrystalsNanocrystals
When the size of the material is reduced to less than 100 When the size of the material is reduced to less than 100 nanometers, the realm of quantum physics takes over and nanometers, the realm of quantum physics takes over and materials begin to demonstrate entirely new properties. materials begin to demonstrate entirely new properties.
Nano-design of drugs by various techniques like milling, Nano-design of drugs by various techniques like milling, high pressure homogenization, controlled precipitation etc., high pressure homogenization, controlled precipitation etc., are explored to produce, drug nanocrystals, nanoparticles, are explored to produce, drug nanocrystals, nanoparticles, nanoprecipitates, nanosuspensions (which for ease of nanoprecipitates, nanosuspensions (which for ease of understanding commonly mentioned as nanocrystals). understanding commonly mentioned as nanocrystals).
As decreased size will increase the solubility of drugs As decreased size will increase the solubility of drugs hence, this technology is explored to increase oral hence, this technology is explored to increase oral bioavailability of sparingly water soluble drugs.bioavailability of sparingly water soluble drugs.
20/03/200820/03/2008 Dept. of PharmaceuticsDept. of Pharmaceutics 2424
MicelleMicelle
20/03/200820/03/2008 Dept. of PharmaceuticsDept. of Pharmaceutics 2525
MicelleMicelle
Micelle is an aggregate of amphipathic molecules in water, with the nonpolar Micelle is an aggregate of amphipathic molecules in water, with the nonpolar portions in the interior and the polar portions at the exterior surface, exposed portions in the interior and the polar portions at the exterior surface, exposed to water. to water.
Amphiphilic molecules form micelle above a particular concentration which is Amphiphilic molecules form micelle above a particular concentration which is called as critical micellar concentration (CMC). called as critical micellar concentration (CMC).
Micelles are known to have an anisotropic water distribution within their Micelles are known to have an anisotropic water distribution within their structure, means water concentration decreases from the surface towards structure, means water concentration decreases from the surface towards the core of the micelle, with a completely hydrophobic (water-excluded) core. the core of the micelle, with a completely hydrophobic (water-excluded) core.
Hydrophobic drugs can be encapsulated/solubalized, into inner core. Hydrophobic drugs can be encapsulated/solubalized, into inner core.
The spatial position of a solubilized drug in a micelle will depend on its The spatial position of a solubilized drug in a micelle will depend on its polarity, nonpolar molecules will be solubilized in the micellar core, and polarity, nonpolar molecules will be solubilized in the micellar core, and substances with intermediate polarity will be distributed along the surfactant substances with intermediate polarity will be distributed along the surfactant molecules in certain intermediate molecules in certain intermediate positions. positions.
20/03/200820/03/2008 Dept. of PharmaceuticsDept. of Pharmaceutics 2626
Dendrimers Dendrimers
20/03/200820/03/2008 Dept. of PharmaceuticsDept. of Pharmaceutics 2727
DendrimersDendrimers
These branched macromolecules are constructed around a These branched macromolecules are constructed around a simple core unit. simple core unit.
Dendrimers have a high degree of molecular uniformity, Dendrimers have a high degree of molecular uniformity, narrow molecular weight distribution, specific size and narrow molecular weight distribution, specific size and shape characteristics, and a highly- functionalized shape characteristics, and a highly- functionalized terminal surface. terminal surface.
The manufacturing process is a series of repetitive steps The manufacturing process is a series of repetitive steps starting with a central initiator core. Each subsequent starting with a central initiator core. Each subsequent growth step represents a new "generation" of polymer with growth step represents a new "generation" of polymer with a larger molecular diameter, twice the number of reactive a larger molecular diameter, twice the number of reactive surface sites, and approximately double the molecular surface sites, and approximately double the molecular weight of the preceding generation.weight of the preceding generation.
20/03/200820/03/2008 Dept. of PharmaceuticsDept. of Pharmaceutics 2828
Polymeric Nanoparticles Polymeric Nanoparticles
20/03/200820/03/2008 Dept. of PharmaceuticsDept. of Pharmaceutics 2929
Polymeric NanoparticlesPolymeric Nanoparticles
In recent years, biodegradable polymeric In recent years, biodegradable polymeric nanoparticles have attracted considerable nanoparticles have attracted considerable attention as potential drug delivery attention as potential drug delivery devices in view of their applications in devices in view of their applications in drug targeting to particular organs/tissues, drug targeting to particular organs/tissues, as carriers of DNA as carriers of DNA in gene therapy, and in their ability to in gene therapy, and in their ability to deliver proteins, peptides and genes deliver proteins, peptides and genes through a per oral route of administration. through a per oral route of administration.
20/03/200820/03/2008 Dept. of PharmaceuticsDept. of Pharmaceutics 3030
Carbon 60Carbon 60
20/03/200820/03/2008 Dept. of PharmaceuticsDept. of Pharmaceutics 3131
Carbon 60 Carbon 60
C60 are spherical molecules about 1nm in C60 are spherical molecules about 1nm in diameter, comprising 60 carbon atoms diameter, comprising 60 carbon atoms arranged as 20 hexagons and 12 pentagons: the arranged as 20 hexagons and 12 pentagons: the configuration of a football. configuration of a football.
Hence they find application as Hence they find application as NanoPharmaceuticals with large drug payload in NanoPharmaceuticals with large drug payload in their cage like structure. their cage like structure.
On the other hand with development of various On the other hand with development of various chemical substitutes for C60, it is possible to chemical substitutes for C60, it is possible to develop functionalized C60 with better drug develop functionalized C60 with better drug targeting properties targeting properties
20/03/200820/03/2008 Dept. of PharmaceuticsDept. of Pharmaceutics 3232
Carbon NanotubeCarbon Nanotube
20/03/200820/03/2008 Dept. of PharmaceuticsDept. of Pharmaceutics 3333
Carbon NanotubeCarbon Nanotube
Carbon nanotubes are adept at entering the Carbon nanotubes are adept at entering the nuclei of cells and may one day be used to nuclei of cells and may one day be used to deliver drugs and vaccines. deliver drugs and vaccines.
The modified nanotubes have so far only been The modified nanotubes have so far only been used to ferry a small peptide into the nuclei of used to ferry a small peptide into the nuclei of fibroblast cells. fibroblast cells.
But the researchers are hopeful that the But the researchers are hopeful that the technique may one day form the basis for new technique may one day form the basis for new anti-cancer treatments, gene therapies and anti-cancer treatments, gene therapies and vaccines.vaccines.
20/03/200820/03/2008 Dept. of PharmaceuticsDept. of Pharmaceutics 3434
Equipments for NanoparticlesEquipments for Nanoparticles
1.Homogenizer
2.Ultra Sonicator
3.Mills
4.Spray Milling
5.Supercritical Fluid Technology
6.Electrospray
7.Ultracentrifugation
8.Nanofiltration
20/03/200820/03/2008 Dept. of PharmaceuticsDept. of Pharmaceutics 3535
Homogenizer & Ultra SonicatorHomogenizer & Ultra Sonicator
20/03/200820/03/2008 Dept. of PharmaceuticsDept. of Pharmaceutics 3636
Methods of Drug DeliveryMethods of Drug Delivery
20/03/200820/03/2008 Dept. of PharmaceuticsDept. of Pharmaceutics 3737
E-mail: [email protected]: [email protected]